BioSpace News Archive

FDA

FDA Approves New Therapy for Triple Negative Breast Cancer That Has Spread, Not Responded to Other Treatments

Today, the U.S. Food and Drug Administration granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with triple-negative breast cancer that has spread to other parts of the body.

April 22, 2020
·
5 min read
CPhI & P-MEC China moves to December date to enable international attendance

CPhI & P-MEC China 2020, the landmark 20th anniversary edition of China’s largest pharma exhibition, will now take place on 16-18 December 2020 at SNIEC in Shanghai [rescheduled from June 22-24, 2020].

April 22, 2020
·
3 min read
Business

Cytokinetics to Announce First Quarter Results on May 6, 2020

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report first quarter results on May 6, 2020 at 4:00 PM Eastern Time.

April 22, 2020
·
3 min read